Introduction
============

Lung cancer is a common malignant tumor, whose incidence and mortality rate show sharp upward trends ([@b1-ol-0-0-7839],[@b2-ol-0-0-7839]). In China, morbidity and mortality rates of lung cancer exhibit an obvious increasing trend. Lung cancer has become the leading cause of mortality compared to other cancer types, and the mortality rate has been increased by 75.77% compared with that in the 1990s ([@b3-ol-0-0-7839]).

In previous years, with the continuous development of thoracoscopic surgery techniques and equipment, thoracoscopic surgery for the radical treatment of lung cancer has drawn increasing attention from clinicians. Thoracoscopic surgery has been widely used in clinical treatment because of small operation wound and rapid postoperative recovery, which provides surgical opportunity for elderly patients with poor cardiopulmonary function ([@b4-ol-0-0-7839]). Previous findings showed that plasma D-dimer is the sign of hypercoagulability and fiber coagulation hyperfunction state. It also has important significance for clinical diagnosis, prognosis and staging of lung cancer ([@b5-ol-0-0-7839],[@b6-ol-0-0-7839]). In addition, researchers have begun to focus on the relationship between serum D-dimer level and different surgical methods (thoracoscopy or thoracotomy) ([@b7-ol-0-0-7839]). In the present study, the feasibility and safety of thoracoscopic surgery for lung cancer were evaluated by retrospective analyses, comparisons of intraoperative and postoperative cases of thoracoscopic surgery and traditional thoracotomy for lung cancer.

Materials and methods
=====================

### General materials

Patients with lung cancer treated in the Department of Thoracic Surgery of Ningbo No. 2 Hospital (Zhejiang, China) from January 1, 2013 to December 31, 2016, were retrospectively analyzed. The study was approved by the Ethics Committee of Ningbo No. 2 Hospital and informed consents was signed by the patients. Inclusion criteria for the study were: i) Patients receiving radical surgery for lung cancer and pathologically diagnosed with lung cancer. Immunohistochemical images for lung squamous cell carcinoma, adenocarcinoma and small cell carcinoma are shown in [Fig. 1A-C](#f1-ol-0-0-7839){ref-type="fig"}, respectively; ii) male or female patients aged 18--70 years; iii) patients whose heart, brain, lung, kidney and other visceral organs functions were well before operation, and who could tolerate operations; iv) patients with no malignant arrhythmia, thyroid dysfunction or past histories; v) patients receiving thoracoscopic surgery who would not choose thoracotomy at the midterm of thoracoscopic surgery or change surgical methods during operation; and vi) patients who did not take anticoagulants recently. A total of 218 patients were included in the study, and divided into the thoracoscopy (n=98) and thoracotomy (n=120) groups according to the different surgical methods. The baseline data of the two groups of patients were compared, and the differences were not statistically significant (P\>0.05) ([Table I](#tI-ol-0-0-7839){ref-type="table"}).

Methods
-------

### Preoperative preparations

Two groups of patients were treated with the same preoperative preparations, including respiratory exercise, smoking cessation, aerosol inhalation, correction of water, and electrolyte disorders. All the patients underwent preoperative computed tomography (CT), chest-enhanced CT and other tests for the confirmation of the diagnosis and stage. Mediastinoscopy and biopsy were not taken as routine examinations. Reserves and the compensatory capacity of the heart, lung, liver and kidney and the preserved skin of all the patients were comprehensively understood and assessed prior to surgery. In addition, before operation, gastrointestinal decompression tube and ureter were indwelt, and broad-spectrum antibiotics were retentively used. After the adequate preparation, surgical treatment was conducted.

### Thoracoscopy group

Patients were placed in the lateral position, and were generally anesthetized through double-lumen endotracheal intubation. Then patients received one-lung ventilation in the lateral recumbent position for radical surgery for lung cancer. The 3-hole method was used for operations: The observation hole with the diameter of 15 mm was located at the 7th and 8th intercostal of the midaxillary line of patients, and the Strykerl088i-30 thoracoscopy was inserted. An operation mouth with the length of 30--50 mm was made at the 4th and 5th intercostal of the anterior axillary line, and a deputy operation mouth with the length of about 20 mm was made at the 6th and 7th intercostal of the posterior axillary line or the 8th intercostal of the infrascapular line. Ribs of patients in the thoracoscopy group were not cut, and not distracted by a distractor. The cut lung lobes were placed in the specimen bag and removed from the operation mouth to protect the incision from the implantation metastasis and wound infection. Routine mediastinal lymphadenectomy in the hilus of the lung was conducted. At the end of the operation, the patients were monitored and treated in the intensive care unit, a breathing machine was used to assist breathing, and vital signs were dynamically monitored. The trachea cannulas were removed under the condition that patients woke up with normal vital signs and blood gas analysis results. Analgesia pumps were not routinely used after operation.

### Thoracotomy group

Radical surgery for lung cancer was completed by accessing the chest through conventional posterior incision.

### D-dimer method

Patients were examined by extracting peripheral blood preoperatively, immediately and 24 h after surgery. The blood was preserved in a citrate anticoagulant vacuum tube for parallel plasma D-dimer determination.

### Observation indexes

The operation time, intraoperative blood loss, blood transfusion, postoperative thoracic drainage time and volume, postoperative hospital stay, the incidence rate from moderate to severe pains in incisions at 6 h after operation (FACES^®^ Pain Rating Scale), the use rate of analgesics, the time of the disappearance of pain in incisions after operation and relevant postoperative complications within the perioperative period of patients were observed. In addition, levels of the serum D-dimer in the two groups of patients before operation, immediately after operation and at 24 h after operation were observed. The change of prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), blood coagulation factor V and VII of patients before and after surgery were also observed and recorded.

### Statistical analysis

SPSS 17.0 (SPSS, Inc., Chicago, IL, USA) statistical software was used for analysis. Measurement data were expressed as mean ± SD. Intergroup comparisons were detected using the t-test, and comparisons among multiple groups or intragroup comparisons were detected using the analysis of variance. Countable data were expressed as a percentage or composition ratio, and intergroup comparisons were detected using the χ^2^ test. Ranked data were expressed as a percentage or composition ratio, and intergroup comparisons were detected using the rank-sum test. Inspection level was α=0.05.

Results
=======

### Intraoperative condition

Operations of all the patients were successfully completed. The blood loss and transfusion rate in the thoracoscopy were significantly lower than those in the thoracotomy group (P\<0.05), but there was no statistically significant difference in the average operation time between the thoracoscopy and thoracotomy groups ([Table II](#tII-ol-0-0-7839){ref-type="table"}).

Postoperative condition
-----------------------

### Postoperative recovery condition

The postoperative hospital stay, the thoracic drainage time and volume in the thoracoscopy group were shorter or smaller than those in the thoracotomy group (P\<0.05) ([Table III](#tIII-ol-0-0-7839){ref-type="table"}). No pain pump was used in both groups. Postoperative pain was assessed by the FACES^®^ Pain Rating Scale at 6 h after operation. The incidence rate of moderate to severe pain in incisions, the use rate of analgesics and the average time of the disappearance of pain in incisions in the thoracoscopy were lower than those in the thoracotomy group (P\<0.05) ([Table III](#tIII-ol-0-0-7839){ref-type="table"}).

### Changes in serum D-dimer after operation

The level of serum D-dimer in the two groups after operation was significantly higher than that before operation, and the serum D-dimer level of patients was further increased at 24 h after operation (P\<0.05). The comparison between the two groups showed that the levels of serum D-dimer in the thoracoscopy group immediately and at 24 h after operation were significantly lower than those in the thoracotomy group (P\<0.05) ([Table IV](#tIV-ol-0-0-7839){ref-type="table"} and [Fig. 2](#f2-ol-0-0-7839){ref-type="fig"}). There was no significant difference of PT, APTT and TT in the two groups before and after surgery (P\>0.05). Coagulation factor V and VII were elevated after surgery compared with those before surgery (P\<0.05). No significant differences were identified between the two groups (P\>0.05) ([Table V](#tV-ol-0-0-7839){ref-type="table"}).

### Postoperative complications

Although the total incidence rate of postoperative complications in the thoracoscopy was lower than that in the thoracotomy group, there was no statistically significant difference between the two groups. Only the incidence rate of wound infection in the thoracoscopy was significantly lower than that in the thoracotomy group (P\<0.05) ([Table VI](#tVI-ol-0-0-7839){ref-type="table"}). Among the patients, there were 28 patients with arrhythmia, which was improved after observation or through treatment with antiarrhythmic drugs; there were 3 patients with atelectasis, which was improved through active expectoration, anti-infection, bronchoscopy suction and other treatments; there were 46 patients with pulmonary infection, which was improved by active expectoration and anti-infection treatments; there were 4 patients with air leak at 5 days after operation, which was stopped by the intrapleural injection of albumins and other treatments; there were 3 patients with empyema, which was improved by receiving thoracic close drainage, rinse, nutrition support and anti-infection treatments; there was 1 patient with thoracic hemorrhage and 1 patient with chylothorax, who were treated with thoracotomy again; and there were 12 patients with wound infection due to obesity and the history of diabetes, who were discharged after the wound dressing was changed and anti-infection treatment was conducted ([Table V](#tV-ol-0-0-7839){ref-type="table"}).

Discussion
==========

Since the 1990s, video-assisted thoracoscopic surgery has been increasingly widely used in the treatment of benign and malignant pulmonary diseases. Compared with traditional thoracotomy, thoracoscopic surgery is characterized by minimal trauma, mild postoperative pain, fewer postoperative complications, short hospital stay, good aesthetic appearance and other advantages ([@b8-ol-0-0-7839]). However, a study has shown that thoracoscopic surgery has no major advantages compared with traditional thoracotomy, but has a long operation time and may increase intraoperative complications ([@b9-ol-0-0-7839]). Kuritzky and Ng ([@b10-ol-0-0-7839]) found that no significant difference was shown regarding the curative effect in the treatment of elderly patients with non-small cell lung cancer between thoracoscopic lung surgery and thoracotomy. Nevertheless, the amount of bleeding and complication conditions are better in thoracoscopic lung surgery with shorter postoperative hospitalization time and lighter early inflammatory reaction. Nwogu *et al* ([@b11-ol-0-0-7839]) suggested that full thoracoscopical lung resection of lymph node dissection in the treatment of peripheral lung cancer is safe, effective, and feasible with less postoperative pleural fluid. It can achieve the effect of conventional thoracic surgery in terms of radical lymph node dissection. Gopaldas *et al* ([@b12-ol-0-0-7839]) showed that the single hole thoracoscopic lobectomy for the treatment of early peripheral lung cancer is a safe and effective operation.

In the present study, the blood loss and transfusion rate in the thoracoscopy were less than those in the thoracotomy group, but the average operation time and postoperative complications in the two groups were equivalent. This was mainly because when the retrospectively analyzed patients were included, the thoracoscopic surgery techniques of the Department of Thoracic Surgery of our hospital has become relatively more mature, and clinicians were relatively more experienced, which obviously made the thoracoscopic surgery more safe and reliable than that before the techniques were advanced. In thoracoscopic surgery, the field of vision is wide and clear, the anatomical structure is clear, the incision is small and the errhysis volume is small, thus leading to little intraoperative blood loss in thoracoscopic surgery. A prospective study of Flores *et al* ([@b13-ol-0-0-7839]) showed that the number of patients with postoperative complications, including atrial fibrillation, persistent pulmonary air leak, atelectasis, and pneumonia, in the thoracoscopy was significantly less than that in the thoracotomy group. However, in the present study, the incidence rate of postoperative complications in the two groups was equivalent, and only the incidence rate of wound infection in the thoracoscopy was significantly lower than that in the thoracotomy group. In our study, complications in the thoracoscopy group were mainly distributed in pulmonary infection and arrhythmia. Pulmonary infection was mainly due to the history of smoking and pulmonary diseases in recent years, while preoperative and postoperative banning on smoking increased the psychological burden of patients. A study has revealed that more than 400 cigarettes a year, combined with basic pulmonary diseases and the forced expiratory volume in one second (FEV1%) less than or equal to 60% are high-risk factors for the incidence of complications of lung cancer surgeries ([@b14-ol-0-0-7839]). At present, it is still controversial whether the incidence rate of postoperative arrhythmia in patients with lung cancer is affected by thoracoscopic surgery or the traditional thoracotomy method. Arrhythmia is a common complication of thoracic tumor surgery, commonly manifesting as atrial fibrillation, and its incidence rate is more than 20% ([@b15-ol-0-0-7839],[@b16-ol-0-0-7839]). The results of the present study indicated that the number of patients with arrhythmia including atrial fibrillation in the thoracoscopy group was not significantly reduced compared with that in the conventional thoracotomy group. This result is similar to that obtained in the study of Park *et al* ([@b17-ol-0-0-7839]). However, a study revealed that the incidence rate of arrhythmia in the pulmonary lobectomy under the thoracoscopy is significantly lower than that in the conventional thoracotomy ([@b18-ol-0-0-7839]).

D-dimer is the product degraded from fibrin polymers under the action of plasmin after fibrin monomers form fibrin polymers through the crosslinking of the activation factor, XIII, and it is a specific index embodying human secondary fibrinolysis hyperthyroidism ([@b19-ol-0-0-7839]). Surgical injury and anesthetic stimulation can lead to increased levels of prothrombin fragment, fibrinopeptide A and other substances, which can alter the coagulation status of the body. In research by Allaix *et al* ([@b20-ol-0-0-7839]), suspected VTE patients with negative D-dimer were followed up for 6 months. Thrombosis occurred in only 1.9% of patients. VTE patients with a high level of D-dimer are usually recovered to a normal status in about a month. In the present study, the levels of serum D-dimer immediately and at 24 h after operation in the two groups were significantly higher than that before operation, and the change in serum D-dimer in the thoracotomy was more obvious than that in the thoracoscopy group. Since the trauma of thoracoscopic surgery is small, the incidence rate of postoperative hypercoagulable state of blood is lower than that of traditional thoracotomy, and similar results have been reported in many articles regarding the thoracoscopic and laparoscopic surgeries ([@b21-ol-0-0-7839]). Previous findings have shown that serum D-dimer level is increased in a variety of malignant tumors, and it is closely related to tumor stage, lymph node metastasis and other factors ([@b22-ol-0-0-7839]). Some studies have indicated that the increased level of serum D-dimer is significantly associated with poor prognosis of lung cancer ([@b6-ol-0-0-7839],[@b19-ol-0-0-7839]). Therefore, the main reason for the increase in serum D-dimer level in this study needs to be further studied.

With the continuous development of thoracoscopic surgery techniques and equipment, radical surgery for lung cancer using thoracoscopy has achieved good results. The advantages of thoracoscopic surgery in the perioperative period have become increasingly apparent, and its relatively reduced effect on the postoperative hypercoagulable state of blood has drawn increasing attention.
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![Immunohistochemical images for: (A) Lung squamous cell carcinoma, (B) adenocarcinoma, and (C) small cell carcinoma.](ol-15-04-4397-g00){#f1-ol-0-0-7839}

![Comparison of serum D-dimer level of patients after operation between the thoracotomy and thoracoscopy groups. The D-dimer content of the two groups is gradually increased with the increase of time, and D-dimer content in the thoracoscopy group is lower than that in the thoracotomy group at the same time point.](ol-15-04-4397-g01){#f2-ol-0-0-7839}

###### 

Comparisons of clinical data of patients between the thoracotomy and the thoracoscopy groups.

  General data                      Thoracotomy group (n=120)   Thoracoscopy group (n=98)   χ^2^/t/Z   P-value
  --------------------------------- --------------------------- --------------------------- ---------- ---------
  Age (years)                       55.63±8.01                  56.04±6.92                  0.792      0.473
  Sex                                                                                                  
    M/F                             68/52                       52/46                       0.280      0.590
  Clinical symptoms, n (%)                                                                             
    Cough                           53 (44.17)                  45 (45.92)                  0.067      0.796
    Expectoration                   20 (16.67)                  10 (10.20)                  2.730      0.099
    Hemoptysis                      32 (26.67)                  24 (24.49)                  0.134      0.714
    Chest distress                  12 (10.00)                  7 (7.14)                    0.554      0.457
    Emaciation                      33 (27.50)                  28 (28.57)                  0.031      0.861
    Pyrexia                         17 (14.17)                  11 (11.22)                  0.417      0.518
    No symptom                      20 (16.67)                  16 (16.33)                  0.005      0.946
  Past history, n (%)                                                                                  
    Smoking                         82 (68.33)                  60 (61.22)                  1.200      0.273
    Hypertension                    23 (19.17)                  16 (16.33)                  0.296      0.586
    Diabetes                        32 (26.67)                  21 (21.43)                  0.804      0.370
    COPD                            34 (28.33)                  19 (19.39)                  2.346      0.126
  The ASA grading, n (%)                                                                               
    Grade I                           42 (35.00)                45 (45.92)                             
    Grade II                          65 (54.17)                45 (45.92)                             
    Grade III                         13 (10.83)                8 (8.16)                               
  Maximum diameter of lesion (cm)   2.81±0.32                   3.05±0.50                   0.469      0.674
  Lesion site, n (%)                                                                        −0.723     0.470
    Left upper lobe                   28 (23.33)                25 (25.51)                             
    Left lower lobe                 16 (13.33)                  15 (15.31)                             
    Right upper lobe                  28 (23.33)                23 (23.47)                             
    Right middle lobe               12 (10.00)                  10 (10.20)                             
    Right lower lobe                36 (30.00)                  25 (25.51)                             
  Pathological type, n (%)                                                                  −1.903     0.057
    Squamous carcinoma              39 (32.50)                  42 (42.86)                             
    Adenocarcinoma                  46 (38.33)                  38 (38.78)                             
    Adeno-squamous carcinoma        18 (15.00)                  10 (10.20)                             
    Others                          17 (14.17)                  8 (8.16)                               
  Pathological stage, n (%)                                                                 −0.444     0.657
    IA                              35 (29.17)                  31 (31.63)                             
    IB                              42 (35.00)                  35 (35.71)                             
    IIA                             16 (13.33)                  12 (12.24)                             
    IIB                             17 (14.17)                  10 (10.20)                             
    IIIA                            9 (7.50)                    10 (10.20)                             
    IIIB                            1 (0.83)                    0                                      
  Serum D-dimer (mg/l)              0.37±0.16                   0.36±0.15                   −0.148     0.882

M/F, male/female; COPD, chronic obstructive pulmonary disease; ASA, American Society of Anesthesiologists.

###### 

Comparison of intraoperative condition of patients between the thoracotomy and thoracoscopy groups.

  Intraoperative condition         Thoracotomy group (n=120)   Thoracoscopy group (n=98)   χ^2^/t   P-value
  -------------------------------- --------------------------- --------------------------- -------- ---------
  Operative time (min)             126.17±39.23                132.23±32.56                1.106    0.276
  Intraoperative blood loss (ml)   234.23±53.72                110.64±18.25                −6.316   \<0.001
  Blood transfusion n (%)          27 (22.50)                  8 (8.16)                    8.227    0.004

###### 

Comparison of postoperative recovery condition of patients between the thoracotomy and thoracoscopy groups.

  Postoperative condition                                                                 Thoracotomy group (n=120)   Thoracoscopy group (n=98)   χ^2^/t    P-value
  --------------------------------------------------------------------------------------- --------------------------- --------------------------- --------- ---------
  Thoracic drainage time (days)                                                           6.27±2.13                   4.38±1.92                   −5.670    \<0.001
  Thoracic drainage volume (ml)                                                           1453.57±611.25              1024.78±556.95              −5.743    \<0.001
  Postoperative hospital stay (days)                                                      13.84±2.31                  10.12±2.56                  −5.694    \<0.001
  Incidence rate of moderate to severe pains in incisions at 6 h after operation, n (%)   72 (60.00)                  20 (20.41)                  34.667    \<0.001
  Use rate of analgesics, n (%)                                                           68 (56.67)                  18 (18.37)                  33.126    \<0.001
  Average time of the disappearance of pain in incisions (h)                              72.58±20.98                 28.67±14.37                 −53.642   \<0.001

###### 

Comparison of changes in serum D-dimer of patients after operation between the thoracotomy and thoracoscopy groups (mg/l).

  Serum D-dimer                 Thoracotomy group (n=120)   Thoracoscopy group (n=98)   t        P-value
  ----------------------------- --------------------------- --------------------------- -------- ---------
  Before operation              0.37±0.16                   0.36±0.15                   −0.148   0.882
  Immediately after operation   0.55±0.26                   0.42±0.19                   4.001    \<0.001
  At 24 h after operation       0.93±0.17                   0.68±0.23                   8.585    \<0.001
  F-value                       277.785                     67.492                               
  P-value                       \<0.001                     \<0.001                              
  P1:2                          \<0.001                     0.132                                
  P1:3                          \<0.001                     \<0.001                              
  P2:3                          \<0.001                     \<0.001                              

###### 

The changes of blood coagulation indexes before and after operation of the two groups (mean ± SD).

  Groups         Time             PT (sec)     APTT (sec)   TT (sec)     Coagulation factor V(g/l)                                Coagulation factor VII(g/l)
  -------------- ---------------- ------------ ------------ ------------ -------------------------------------------------------- --------------------------------------------------------
  Thoracoscopy   Before surgery   12.32±0.87   28.65±2.65   17.32±2.34   2.19±0.43                                                2.19±0.43
                 After surgery    12.88±0.88   31.22±2.12   18.32±3.02   1.81±0.32^[a](#tfn3-ol-0-0-7839){ref-type="table-fn"}^   1.81±0.32^[a](#tfn3-ol-0-0-7839){ref-type="table-fn"}^
  Thoracotomy    Before surgery   12.45±0.98   28.98±2.01   17.43±2.19   2.23±0.52                                                2.23±0.52
                 After surgery    12.78±0.97   32.43±1.35   18.97±3.21   1.82±0.54^[a](#tfn3-ol-0-0-7839){ref-type="table-fn"}^   1.82±0.54^[a](#tfn3-ol-0-0-7839){ref-type="table-fn"}^

Compared with that before surgery

P\<0.05; SD, standard deviation; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time.

###### 

Comparison of condition of postoperative complications of patients between the thoracotomy and thoracoscopy groups \[n (%)\].

  Complication                           Thoracotomy group (n=120)   Thoracoscopy group (n=98)   χ^2^    P-value
  -------------------------------------- --------------------------- --------------------------- ------- ---------
  Arrhythmia                             17 (14.17)                  11 (11.22)                  0.417   0.518
    Atrial fibrillation                  10 (8.33)                   6 (6.12)                    0.388   0.533
    Supraventricular tachycardia         4 (3.33)                    5 (5.10)                    0.055   0.815
    Ventricular premature beat           1 (0.83)                    0                           0.000   1.000
    Ventricular fibrillation             0                           0                           0.000   1.000
    Sinus bradycardia                    2 (1.67)                    0                           0.325   0.569
  Lung                                                                                                   
    Atelectasis                          1 (0.83)                    2 (2.04)                    0.031   0.860
    Pulmonary infection                  26 (21.67)                  20 (20.41)                  0.051   0.821
    Pulmonary air leak after operation   2 (1.67)                    2 (2.04)                    0.000   1.000
  Empyema                                2 (1.67)                    1 (1.02)                    0.000   1.000
  Chylothorax                            1 (0.83)                    0                           0.000   1.000
  Thoracic hemorrhage                    0                           1 (1.02)                    0.000   1.000
  Incision infection                     10 (8.33)                   2 (2.04)                    4.106   0.043
  Deep venous thrombosis                 3 (2.50)                    0                           0.984   0.321
  Total                                  62 (51.67)                  39 (39.80)                  3.057   0.080
